Equities

Craneware PLC

CRW:LSE

Craneware PLC

Health CareHealth Care Providers
  • Price (GBX)2,259.60
  • Today's Change-30.40 / -1.33%
  • Shares traded10.18k
  • 1 Year change93.96%
  • Beta0.5655
Data delayed at least 20 minutes, as of Apr 25 2024 12:00 BST.
More ▼

IC View

The last IC recommendation on Craneware PLC shares was Buy at 2,140.00 on 04 Mar 2024Read the full article

Key statistics

Craneware PLC (CRW:LSE) set a new 52-week high during Wednesday's trading session when it reached 2,290.00. Over this period, the share price is up 83.71%.
52-week range
Today
1,142.00Apr 26 20232,290.00Apr 24 2024
Short selling activity
Low
Med
High
Provided by S&P Global Market Intelligence
Open2,275.00
High2,259.60
Low2,210.00
Bid2,250.00
Offer2,280.00
Previous close2,290.00
Average volume175.61k
Shares outstanding35.33m
Free float27.97m
P/E (TTM)107.46
Market cap808.23m GBP
EPS (TTM)0.2129 GBP
Annual div (ADY)29.00 GBX
Annual div yield (ADY)1.30%
Div ex-dateMar 21 2024
Div pay-dateApr 15 2024
Data delayed at least 20 minutes, as of Apr 25 2024 12:00 BST.
More ▼
Data Provided by LSEG
All markets data located on InvestorsChronicle.co.uk is subject to the Investors Chronicle Terms & Condition
All content on InvestorsChronicle.co.uk is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by IC and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via Investors Chronicle is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. Investors Chronicle is not responsible for any use of content by you outside its scope as stated in the Investors Chronicle Terms & Condition.
S&P Global Market Intelligence Short Selling Activity © S&P Global Market Intelligence. All rights reserved.
Although S&P Global Market Intelligence has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of S&P Global Market Intelligence on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.